1. Home
  2. MGTX

MGTX

MeiraGTx Holdings plc

Logo MeiraGTx Holdings plc

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Founded: 2015 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 367.3M IPO Year: N/A
Target Price: $25.67 AVG Volume (30 days): 148.2K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.49 EPS Growth: N/A
52 Week Low/High: $3.49 - $8.35 Next Earning Date: 05-09-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 389.47%

Share on Social Networks: